Search the Newsreel

Boise Cascade (NYSE:BCC) Upgraded to "Buy" at Wall Street Zen

Boise Cascade (NYSE:BCC) received an upgrade from "Hold" to "Buy" by Wall Street Zen, despite the broader analyst consensus remaining at "Hold" with an average price target of $93.60. The company's shares increased by 2.9%, trading near its 12-month high and above moving averages, …

Ascentage Pharma Group International (AAPG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ascentage Pharma Group International (AAPG), highlighting that 9 analysts currently recommend a "Buy" rating with a target price indicating a significant upside. The report includes current stock performance and a peer comparison, but notes that specific financial …

Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) and its officers, alleging violations of federal securities laws. The lawsuit claims that Erasca made misleading statements regarding ERAS-0015's preclinical data, which was based on improper comparisons and …

Cascades (TSX:CAS) Stock Rally Faces Slower Earnings Momentum

Ardmore Shipping (ASC) Q2 2026 Earnings Call Transcript

Masco Corporation (NYSE:MAS) Given Average Recommendation of "Hold" by Analysts

Analysts have given Masco Corporation (NYSE:MAS) an average "Hold" rating, with a consensus 12-month price target of $79.87. The company recently reported strong quarterly earnings per share of $1.64, surpassing estimates, despite a slight year-over-year revenue decline. Masco also announced a quarterly dividend and …

Top Stock Market Highlights of the Week: Grab Holdings, UOB, SpaceX and CapitaLand Ascott Trust

Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc. - ERAS

Kahn Swick & Foti, LLC (KSF) is reminding investors with losses exceeding $100,000 in Erasca, Inc. (ERAS) to file lead plaintiff applications by August 10, 2026, in a securities class action lawsuit. The lawsuit alleges that Erasca and its executives made false and misleading …

TerrAscend Posts Higher Q2 Revenue, Boosts Cash Flow and Extends Debt Maturities

Ardmore Shipping (ASC): Scorpio Holdings and Lolli-Ghetti report no remaining shares

Scorpio Holdings Limited and Annalisa Lolli-Ghetti have filed an amended Schedule 13G for Ardmore Shipping Corporation (ASC), indicating that they no longer hold any shares of the company as of the amendment date. Previously, they reported beneficial ownership of 1,529,897 common shares, representing 3.7% …

Burcon NutraScience Schedules Q1 Fiscal 2027 Earnings Call for August 12, 2026

31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update

LeMaitre Vascular (LMAT) reported strong Q2 2026 results with increased sales and net income, affirming its quarterly dividend. While analysts view the stock as 31.4% undervalued with a fair value of $118.75 due to a strong product pipeline and pricing power, Simply Wall St's …

Quanex, Titan International, ESCO, Boise Cascade, and ChargePoint Stocks Trade Up and Down, What You Need To Know

Following an unexpected July jobs report indicating a cooling labor market and a potential Federal Reserve interest rate cut, several stocks experienced mixed trading. Quanex, Titan International, Boise Cascade, and ChargePoint saw their shares rise, while ESCO's stock fell. The market's reaction suggests that …

ERASCA LEAD PLAINTIFF DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors with Large Losses to Contact the Firm Regarding their Rights

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Erasca, Inc. (ERAS) on behalf of investors who purchased stock between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made misleading statements regarding its drug ERAS-0015, which was …

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?

ERAS UPCOMING DEADLINE : The Gross Law Firm Alerts Erasca,

The Gross Law Firm has issued a notice to shareholders of Erasca, Inc. (NASDAQ: ERAS) regarding a securities class action lawsuit. The complaint alleges that Erasca made materially false and/or misleading statements concerning ERAS-0015's preclinical data and its potential violation of patent and trade …

Boise Cascade Stock (BCC) Opinions on Q2 Earnings and Analyst Upgrades

State Street discloses 5.3% Masco Corp (NYSE: MAS) ownership stake

State Street Corporation has disclosed a 5.3% ownership stake in Masco Corp (NYSE: MAS) through a Schedule 13G SEC filing. This amounts to 10,737,096 shares of common stock, primarily held with shared voting and dispositive powers through various State Street Global Advisors entities. The …

Boise Cascade director Kristopher Matula sells $163,239 in shares By Investing.com

Cascades returns to profit in Q2 as sales rise

Cascades has reported net earnings of C$21m ($14.9m) in the second quarter (Q2) of 2026, compared with a net loss of C$3m in the same quarter of 2025. The packaging company's sales reached C$1.2bn in the quarter, versus C$1.1bn in Q2 2025. Its operating …

DDP Shipping Risks: What Boise Cascade’s Guilty Plea Means for U.S. Buyers

The article discusses the risks associated with Delivered Duty Paid (DDP) shipping arrangements, particularly in light of Boise Cascade's recent guilty plea for importing illegally sourced plywood. It highlights how DDP, while convenient, can obscure customs fraud like undervaluation and false classifications, exposing U.S. …

Banca Monte Dei Paschi Siena Aktie: Gewinnplus trotz Übernahmepoker

Erasca Shareholder Alert: ClaimsFiler Reminds Investors

ClaimsFiler is reminding investors in Erasca, Inc. (NasdaqGS: ERAS) that they have until August 10, 2026, to apply for lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Erasca and its executives failed to disclose material information regarding the preclinical data …

Why Cascades (TSX:CAS) Is Up 15.8% After Swinging Back To Profit On Steady Sales

Boise Cascade Company Just Recorded A 31% EPS Beat: Here's What Analysts Are Forecasting Next

Boise Cascade Company reported strong second-quarter results, with revenues beating expectations by 3.4% and an impressive 31% EPS beat. Following these results, analysts have become more bullish, upgrading their earnings per share estimates for 2026 to US$3.95, reflecting a 30% surge. However, the consensus …

Renascor Resources (ASX:RNU) moves into focus as project progress

TerrAscend Corp. 2026 Q2 - Results - Earnings Call Presentation (TSX:TSND:CA) 2026-08-06

Ascendis Pharma (ASND) Could Be 20% Undervalued Following Its Recent Pullback

Ascendis Pharma (ASND) has experienced a recent pullback, with its stock down about 9% over the past month. Despite this, a common valuation narrative suggests the company is 19.8% undervalued, with a fair value of $304.60 compared to its current share price of $244.20. …

ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Erasca, Inc. (NASDAQ:ERAS) on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made misleading statements regarding ERAS-0015's preclinical data, which was …

Ascendis plans Aug. 13 webcast before U.S. markets open

Ascendis Pharma (Nasdaq: ASND) will report its second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the U.S. market opens. The company will host a conference call and live webcast at 8:00 a.m. Eastern Time, with a …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines - ERAS

Pomerantz LLP has announced a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) for alleged securities fraud, urging investors with losses to come forward by the August 10, 2026, deadline. The lawsuit stems from two significant stock drops in April 2026. The first followed …

Impressive Earnings May Not Tell The Whole Story For Ardmore Shipping (NYSE:ASC)

Ardmore Shipping Corp. (NYSE:ASC) reported strong earnings, leading to a share price increase. However, analysis suggests that the reported profit was significantly boosted by US$12m worth of "unusual items," which are typically one-off events. This raises concerns that the company's true underlying earnings power …

Cascades (TSX:CAS) Is Up 15.8% After Swinging Back to Profit in Q2 2026 – What's Changed

LeMaitre management to meet investors at virtual Aug. 11 event

LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The event will be held in a virtual format. The company specializes in devices …

Masco Corp. stock underperforms Thursday when compared to competitors

Masco Corp. stock (MAS) fell by 2.39% to $75.47 on Thursday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also declined. This marked the end of a three-day winning streak for Masco Corp.'s stock.

Kaplan Fox Urges Erasca, Inc. (NASDAQ: ERAS) Investors to Contact the Firm Before the Deadline on August 10, 2026

Kaplan Fox & Kilsheimer LLP is urging investors of Erasca, Inc. (NASDAQ: ERAS) to contact the firm by the August 10, 2026 deadline to serve as lead plaintiff in a class action lawsuit. The lawsuit alleges that Erasca made false and misleading statements regarding …